From: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
Number of patients
62
Age (years; median and range)
70.5 (20–83)
Sex
Male
40
Female
22
FAB subtype
RA
17
RARS
2
RAEB
35
RAEB-t
5
CMML
3
IPSS risk category
Low
Intermediate I
Intermediate II
30
High
10
Del(7q) or -7 (%)
11 (18)